These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 31735550)
1. Celastrol-induced degradation of FANCD2 sensitizes pediatric high-grade gliomas to the DNA-crosslinking agent carboplatin. Metselaar DS; Meel MH; Benedict B; Waranecki P; Koster J; Kaspers GJL; Hulleman E EBioMedicine; 2019 Dec; 50():81-92. PubMed ID: 31735550 [TBL] [Abstract][Full Text] [Related]
2. Celastrol induces proteasomal degradation of FANCD2 to sensitize lung cancer cells to DNA crosslinking agents. Wang GZ; Liu YQ; Cheng X; Zhou GB Cancer Sci; 2015 Jul; 106(7):902-8. PubMed ID: 25891850 [TBL] [Abstract][Full Text] [Related]
3. FANCD2 expression affects platinum response and further characteristics of high grade serous ovarian cancer in cells with different genetic backgrounds. Taylor SJ; Hollis RL; Gourley C; Herrington CS; Langdon SP; Arends MJ Exp Mol Pathol; 2024 Aug; 138():104916. PubMed ID: 38959632 [TBL] [Abstract][Full Text] [Related]
4. Delayed formation of FancD2 foci in glioma stem cells treated with ionizing radiation. Cappelli E; Vecchio D; Frosina G J Cancer Res Clin Oncol; 2012 May; 138(5):897-9. PubMed ID: 22484854 [TBL] [Abstract][Full Text] [Related]
5. Centipeda minima extract sensitizes lung cancer cells to DNA-crosslinking agents via targeting Fanconi anemia pathway. Fan XZ; Chen YF; Zhang SB; He DH; Wei SF; Wang Q; Pan HF; Liu YQ Phytomedicine; 2021 Oct; 91():153689. PubMed ID: 34446320 [TBL] [Abstract][Full Text] [Related]
6. Regulation of FANCD2 by the mTOR pathway contributes to the resistance of cancer cells to DNA double-strand breaks. Shen C; Oswald D; Phelps D; Cam H; Pelloski CE; Pang Q; Houghton PJ Cancer Res; 2013 Jun; 73(11):3393-401. PubMed ID: 23633493 [TBL] [Abstract][Full Text] [Related]
7. Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas. Pal S; Kozono D; Yang X; Fendler W; Fitts W; Ni J; Alberta JA; Zhao J; Liu KX; Bian J; Truffaux N; Weiss WA; Resnick AC; Bandopadhayay P; Ligon KL; DuBois SG; Mueller S; Chowdhury D; Haas-Kogan DA Cancer Res; 2018 Jul; 78(14):4007-4021. PubMed ID: 29760046 [TBL] [Abstract][Full Text] [Related]
8. Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy. Zuckermann M; He C; Andrews J; Bagchi A; Sloan-Henry R; Bianski B; Xie J; Wang Y; Twarog N; Onar-Thomas A; Ernst KJ; Yang L; Li Y; Zhu X; Ocasio JK; Budd KM; Dalton J; Li X; Chepyala D; Zhang J; Xu K; Hover L; Roach JT; Chan KC; Hofmann N; McKinnon PJ; Pfister SM; Shelat AA; Rankovic Z; Freeman BB; Chiang J; Jones DTW; Tinkle CL; Baker SJ Mol Cancer; 2024 Jun; 23(1):123. PubMed ID: 38849845 [TBL] [Abstract][Full Text] [Related]
9. Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux. Wen ZP; Zeng WJ; Chen YH; Li H; Wang JY; Cheng Q; Yu J; Zhou HH; Liu ZZ; Xiao J; Chen XP J Exp Clin Cancer Res; 2019 Jul; 38(1):298. PubMed ID: 31291988 [TBL] [Abstract][Full Text] [Related]
10. Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. Bogliolo M; Lyakhovich A; Callén E; Castellà M; Cappelli E; Ramírez MJ; Creus A; Marcos R; Kalb R; Neveling K; Schindler D; Surrallés J EMBO J; 2007 Mar; 26(5):1340-51. PubMed ID: 17304220 [TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma. Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423 [TBL] [Abstract][Full Text] [Related]
13. A novel role for Fanconi anemia (FA) pathway effector protein FANCD2 in cell cycle progression of untransformed primary human cells. Song IY; Barkley LR; Day TA; Weiss RS; Vaziri C Cell Cycle; 2010 Jun; 9(12):2375-88. PubMed ID: 20519958 [TBL] [Abstract][Full Text] [Related]
14. Silencing of FANCI Promotes DNA Damage and Sensitizes Ovarian Cancer Cells to Carboplatin. Li Y; Zhang Y; Yang Q; Zhou X; Guo Y; Ding F; Liu Z; Luo A Curr Cancer Drug Targets; 2022; 22(7):591-602. PubMed ID: 35362384 [TBL] [Abstract][Full Text] [Related]
16. Alcohol induces DNA damage and the Fanconi anemia D2 protein implicating FANCD2 in the DNA damage response pathways in brain. Rulten SL; Hodder E; Ripley TL; Stephens DN; Mayne LV Alcohol Clin Exp Res; 2008 Jul; 32(7):1186-96. PubMed ID: 18482162 [TBL] [Abstract][Full Text] [Related]
17. Proteasome function is required for DNA damage response and fanconi anemia pathway activation. Jacquemont C; Taniguchi T Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210 [TBL] [Abstract][Full Text] [Related]
18. A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage. Chen X; Bosques L; Sung P; Kupfer GM Oncogene; 2016 Jan; 35(1):22-34. PubMed ID: 25893307 [TBL] [Abstract][Full Text] [Related]
19. Targeting reduced mitochondrial DNA quantity as a therapeutic approach in pediatric high-grade gliomas. Shen H; Yu M; Tsoli M; Chang C; Joshi S; Liu J; Ryall S; Chornenkyy Y; Siddaway R; Hawkins C; Ziegler DS Neuro Oncol; 2020 Jan; 22(1):139-151. PubMed ID: 31398252 [TBL] [Abstract][Full Text] [Related]
20. Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven. Wang Y; Wiltshire T; Senft J; Wenger SL; Reed E; Wang W Mol Cancer Ther; 2006 Dec; 5(12):3153-61. PubMed ID: 17172419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]